Literature DB >> 4382527

Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections.

G F Thornton, V T Andriole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4382527      PMCID: PMC2591244     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


× No keyword cloud information.
  12 in total

1.  LABORATORY EVALUATIOON OF A NEW ANTIBIOTIC--CEPHALORIDINE (CEPORIN).

Authors:  P W MUGGLETON; C H O'CALLAGHAN; W K STEVENS
Journal:  Br Med J       Date:  1964-11-14

2.  POST-TRANSFUSION ANICTERIC HEPATITIS.

Authors:  C L HAMPERS; D PRAGER; J R SENIOR
Journal:  N Engl J Med       Date:  1964-10-08       Impact factor: 91.245

3.  THE EFFECT OF DIETHYLSTILBESTROL ON THE SUSCEPTIBILITY OF RATS TO HEMATOGENOUS PYELONEPHRITIS.

Authors:  V T ANDRIOLE; G L COHN
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

4.  LABORATORY AND CLINICAL RESULTS WITH CEPHALORIDINE.

Authors:  G T STEWART; R J HOLT
Journal:  Lancet       Date:  1964-12-19       Impact factor: 79.321

5.  STUDIES ON THE EPIDEMIOLOGY OF ADVERSE DRUG REACTIONS. I. METHODS OF SURVEILLANCE.

Authors:  L E CLUFF; G F THORNTON; L G SEIDL
Journal:  JAMA       Date:  1964-06-15       Impact factor: 56.272

6.  LONG-TERM THERAPY WITH OXACILLIN IN PATIENTS WITH CYSTIC FIBROSIS.

Authors:  N N HUANG; A SPROUL; V PROMADHATTAVEDI; R H HIGH
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

7.  HETEROZYGOUS BETA-THALASSEMIA IN ASSOCIATION WITH HEREDITARY ELLIPTOCYTOSIS: A FAMILY STUDY.

Authors:  P E PERILLIE; A I CHERNOFF
Journal:  Blood       Date:  1965-04       Impact factor: 22.113

8.  ANAPHYLACTOID REACTION TO AN INITIAL DOSE OF SODIUM CEPHALOTHIN.

Authors:  S A KABINS; B EISENSTEIN; S COHEN
Journal:  JAMA       Date:  1965-07-12       Impact factor: 56.272

9.  Comparison of single-disc and tube-dilution techniques in determining antibiotic sensitivities of gram-negative pathogens.

Authors:  M TURCK; R I LINDEMEYER; R G PETERSDORF
Journal:  Ann Intern Med       Date:  1963-01       Impact factor: 25.391

10.  CLINICAL TRIAL OF CEPHALORIDINE (CEPORIN), A NEW BROAD-SPECTRUM ANTIBIOTIC DERIVED FROM CEPHALOSPORIN C.

Authors:  J M MURDOCH; C F SPEIRS; A M GEDDES; E T WALLACE
Journal:  Br Med J       Date:  1964-11-14
View more
  5 in total

1.  Sensitivity of penicillinase-forming strains of Staphylococcus aureus and of their penicillinase-negative variants to cephaloridine, cephalothin, methicillin, and benzylpenicillin.

Authors:  J H Hewitt; M T Parker
Journal:  J Clin Pathol       Date:  1968-01       Impact factor: 3.411

2.  Thymidylate Limitation Potentiates Cephalosporin Activity toward Enterococci via an Exopolysaccharide-Based Mechanism.

Authors:  Jessica S Hoff; Christopher J Kristich
Journal:  ACS Chem Biol       Date:  2016-03-23       Impact factor: 5.100

3.  Clinical studies of cefazolin and comparison with other cephalosporins.

Authors:  T Madhavan; E L Quinn; E Freimer; E J Fisher; F Cox; K Burch; D Pohlod
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

4.  Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections.

Authors:  J L Boyer; V T Andriole
Journal:  Yale J Biol Med       Date:  1968-02

5.  Cephalexin: clinical and laboratory studies.

Authors:  R W Lyons; V T Andriole
Journal:  Yale J Biol Med       Date:  1971-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.